Kadmon Holdings Inc Receivables Turnover Ratio (KDMN), from the third quarter 2021 to the third quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Kadmon holdings inc   (NASDAQ: KDMN)
 

Kadmon Holdings Inc Accounts Receivables Turnover Ratio from the third quarter 2021 to the third quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Kadmon Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2021 to a ratio of 2.96, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Kadmon Holdings Inc in Sep 30 2021 quarter, has decreased to 123 days, compared to 202 days, in the Jun 30 2021 quarter.

If we take a look into Healthcare sector 538 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2021 from 3266 to 3350.

What is Receivable Turnover Ratio?
What is Kadmon Holdings Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

KDMN Receivables Turnover Ratio (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Receivable Change 4719.03 % 289.65 % 23.1 % -27.15 % -45.71 %
Y / Y Revenue Change 2901.22 % -56.03 % -91.64 % -86.03 % 116.81 %
Receivable Turnover Ratio (TTM) 2.96 1.81 2.84 12.29 16.33
KDMN's Total Ranking # 3350 # 3266 # 3370 # 3266 # 3266
Accounts Receivable average collection period days 123 202 129 30 22
Seq. Receivable Change 1064.94 % 1.58 % 118.56 % 86.33 % -5.81 %
Seq. Revenue Change 7364.97 % -65.01 % -8.46 % 25.51 % 9.37 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 195
Healthcare Sector # 539
Overall Market # 3350

Receivable Turnover Ratio Statistics
High Average Low
23.74 9.42 0.81
(Mar 31 2017)   (Sep 30 2019)





KDMN Company Profile • Back to KDMN Efficiency Comparisons • Compare KDMN Receivables Turnover Ratio to its Competitors

Financial Statements
Kadmon Holdings Inc 's Accounts Receivable $ 18 Millions Visit KDMN's Balance sheet
Kadmon Holdings Inc 's Sales TTM $ 16 Millions Visit KDMN's Income Statement
Sources of KDMN's Revenues Visit KDMN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
KDMN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
KDMN's Growth Rates KDMN's Roa KDMN's Inventory Turnover Ratio KDMN's Dividend Comparisons
KDMN's Profitability Ratios KDMN's Roi KDMN's Asset Turnover Ratio KDMN's Dividend Growth
KDMN's Valuation Ratios KDMN's Roe KDMN's Financial Strength Ratios KDMN's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2021 Receivable at quarter ending Sep 30 2021
Avalo Therapeutics Inc   2.46 $ 6.674  Millions$ 2.716  Millions
Ocular Therapeutix Inc   2.40 $ 38.562  Millions$ 16.042  Millions
Electromed Inc   2.34 $ 37.753  Millions$ 16.143  Millions
Humanigen Inc  2.29 $ 2.870  Millions$ 1.253  Millions
Ani Pharmaceuticals Inc  2.20 $ 212.459  Millions$ 96.758  Millions
Alpine Immune Sciences Inc   2.18 $ 24.670  Millions$ 11.336  Millions
Igc Pharma Inc   2.12 $ 0.322  Millions$ 0.152  Millions
Regenxbio Inc   2.10 $ 93.137  Millions$ 44.429  Millions
Heron Therapeutics Inc   2.08 $ 86.296  Millions$ 41.519  Millions
Venus Concept Inc   1.96 $ 98.818  Millions$ 50.426  Millions
Aerie Pharmaceuticals Inc   1.84 $ 104.151  Millions$ 56.472  Millions
Biohaven Ltd   1.76 $ 307.610  Millions$ 174.617  Millions
Evofem Biosciences Inc   1.74 $ 4.842  Millions$ 2.780  Millions
Journey Medical Corp  1.74 $ 55.064  Millions$ 31.630  Millions
One World Products Inc   1.49 $ 0.030  Millions$ 0.020  Millions
Summit Therapeutics Inc   1.42 $ 1.743  Millions$ 1.229  Millions
Vyne Therapeutics Inc   1.41 $ 16.749  Millions$ 11.882  Millions
Jaguar Health Inc   1.36 $ 4.832  Millions$ 3.560  Millions
Lexaria Bioscience Corp   1.29 $ 0.723  Millions$ 0.560  Millions
China Health Industries Holdings Inc   1.28 $ 4.301  Millions$ 3.363  Millions
Assure Holdings Corp   1.20 $ 8.546  Millions$ 7.104  Millions
Cardiff Oncology Inc   1.09 $ 0.345  Millions$ 0.316  Millions
Kala Bio inc   1.00 $ 11.622  Millions$ 11.575  Millions
Zomedica Corp   0.99 $ 0.041  Millions$ 0.041  Millions
Altimmune inc   0.91 $ 3.533  Millions$ 3.862  Millions
Inovio Pharmaceuticals Inc   0.77 $ 8.980  Millions$ 11.593  Millions
Regen Biopharma Inc   0.70 $ 0.116  Millions$ 0.165  Millions
Vaxxinity Inc   0.53 $ 0.050  Millions$ 0.095  Millions

Date modified: 2026-09-08T15:10:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.